Lipocortin 1 co-associates with cytokeratins 8 and 18 in A549 cells via the N-terminal domain
Jamie D. Croxtall(William Harvey Research Institute), Rod Flower(Queen Mary University of London), Bi-Ing Chang(National Cheng Kung University), Chris W. Sutton(Hemel Hempstead Hospital), Hsi‐Yuan Yang(National Cheng Kung University), Bryan Smith(Armed Forces Health Surveillance Center), Guey‐Yueh Shi(National Cheng Kung University), Hua‐Lin Wu(Shanghai Estuarine & Coastal Science Research Center)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
January 1, 1998
Cited by 15
Related Papers
The development of COX2 inhibitors
|Nature Reviews Drug Discovery|2003|464
Lipocortin-1: cellular mechanisms and clinical relevance
|Trends in Pharmacological Sciences|1994|380
Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor‐dependent, transcription‐independent mechanism
|British Journal of Pharmacology|2000|330
A novel role for phospholipase A <sub>2</sub> isoforms in the checkpoint control of acute inflammation
|The FASEB Journal|2004|173
Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells
|British Journal of Pharmacology|2002|146